These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24550402)

  • 1. Polymorphisms in the human inhibitory signal-regulatory protein α do not affect binding to its ligand CD47.
    Hatherley D; Lea SM; Johnson S; Barclay AN
    J Biol Chem; 2014 Apr; 289(14):10024-8. PubMed ID: 24550402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant protein D (Sp-D) binds to membrane-proximal domain (D3) of signal regulatory protein α (SIRPα), a site distant from binding domain of CD47, while also binding to analogous region on signal regulatory protein β (SIRPβ).
    Fournier B; Andargachew R; Robin AZ; Laur O; Voelker DR; Lee WY; Weber D; Parkos CA
    J Biol Chem; 2012 Jun; 287(23):19386-98. PubMed ID: 22511785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of signal-regulatory protein alpha: a link to antigen receptor evolution.
    Hatherley D; Graham SC; Harlos K; Stuart DI; Barclay AN
    J Biol Chem; 2009 Sep; 284(39):26613-9. PubMed ID: 19628875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.
    Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC
    J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47.
    Hatherley D; Graham SC; Turner J; Harlos K; Stuart DI; Barclay AN
    Mol Cell; 2008 Jul; 31(2):266-77. PubMed ID: 18657508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.
    Barclay AN; Van den Berg TK
    Annu Rev Immunol; 2014; 32():25-50. PubMed ID: 24215318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of the macrophage signal regulatory protein alpha (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors.
    Hatherley D; Harlos K; Dunlop DC; Stuart DI; Barclay AN
    J Biol Chem; 2007 May; 282(19):14567-75. PubMed ID: 17369261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phylogenetic divergence of CD47 interactions with human signal regulatory protein alpha reveals locus of species specificity. Implications for the binding site.
    Subramanian S; Boder ET; Discher DE
    J Biol Chem; 2007 Jan; 282(3):1805-18. PubMed ID: 17098740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cis dimerization of signal regulatory protein alpha (SIRPalpha) in binding to CD47.
    Lee WY; Weber DA; Laur O; Stowell SR; McCall I; Andargachew R; Cummings RD; Parkos CA
    J Biol Chem; 2010 Dec; 285(49):37953-63. PubMed ID: 20826801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology.
    Burgess TL; Amason JD; Rubin JS; Duveau DY; Lamy L; Roberts DD; Farrell CL; Inglese J; Thomas CJ; Miller TW
    PLoS One; 2020; 15(4):e0226661. PubMed ID: 32240171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and Characterization of FD164, a High-Affinity Signal Regulatory Protein
    Wang Z; Hu N; Li X; Wang H; Ren C; Qiao C; Chen G; Wang J; Zhou L; Wu J; Zhang D; Feng J; Shen B; Peng H; Luo L
    Mol Pharmacol; 2021 Sep; 100(3):193-202. PubMed ID: 34315811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47.
    Liu Y; Tong Q; Zhou Y; Lee HW; Yang JJ; Bühring HJ; Chen YT; Ha B; Chen CX; Yang Y; Zen K
    J Mol Biol; 2007 Jan; 365(3):680-93. PubMed ID: 17070842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of CD47 and signal-regulatory protein-α constituting the "don't eat me signal" is a prognostic factor in diffuse large B-cell lymphoma.
    Kazama R; Miyoshi H; Takeuchi M; Miyawaki K; Nakashima K; Yoshida N; Kawamoto K; Yanagida E; Yamada K; Umeno T; Suzuki T; Kato K; Takizawa J; Seto M; Akashi K; Ohshima K
    Cancer Sci; 2020 Jul; 111(7):2608-2619. PubMed ID: 32342603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomimetic Design of Peptide Inhibitor to Block CD47/SIRPα Interactions.
    Zheng S; Ji Y; Li N; Zhang L
    Langmuir; 2023 Dec; 39(49):18101-18112. PubMed ID: 38038444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antitumor peptide RS17-targeted CD47, design, synthesis, and antitumor activity.
    Wang X; Wang Y; Hu J; Xu H
    Cancer Med; 2021 Mar; 10(6):2125-2136. PubMed ID: 33629544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions.
    Baumann N; Rösner T; Jansen JHM; Chan C; Marie Eichholz K; Klausz K; Winterberg D; Müller K; Humpe A; Burger R; Peipp M; Schewe DM; Kellner C; Leusen JHW; Valerius T
    Cancer Sci; 2021 Aug; 112(8):3029-3040. PubMed ID: 34058788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
    Miller TW; Amason JD; Garcin ED; Lamy L; Dranchak PK; Macarthur R; Braisted J; Rubin JS; Burgess TL; Farrell CL; Roberts DD; Inglese J
    PLoS One; 2019; 14(7):e0218897. PubMed ID: 31276567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological analysis of immunohistochemical expression of CD47 and SIRPα in adult T-cell leukemia/lymphoma.
    Yanagida E; Miyoshi H; Takeuchi M; Yoshida N; Nakashima K; Yamada K; Umeno T; Shimasaki Y; Furuta T; Seto M; Ohshima K
    Hematol Oncol; 2020 Dec; 38(5):680-688. PubMed ID: 32569413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel CD47: SIRPα dependent mechanism for the activation of STAT3 in antigen-presenting cell.
    Toledano N; Gur-Wahnon D; Ben-Yehuda A; Rachmilewitz J
    PLoS One; 2013; 8(9):e75595. PubMed ID: 24073274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal-regulatory protein α from the NOD mouse binds human CD47 with an exceptionally high affinity-- implications for engraftment of human cells.
    Kwong LS; Brown MH; Barclay AN; Hatherley D
    Immunology; 2014 Sep; 143(1):61-7. PubMed ID: 24786312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.